Alignment Healthcare, Inc.
13.03USD
-0.4300 (-3.19%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 1.4B | 1.8B | 2.7B | 3.9B | 5.2B | 6.5B |
| Q1 | 345.3M | 434.8M | 628.6M | 926.9M | 1.2B | — |
| Q2 | 366.2M | 456.9M | 681.3M | 1.0B | 1.3B | — |
| Q3 | 360.0M | 450.2M | 692.4M | 993.7M | 1.3B | — |
| Q4 | 360.1M* | 459.0M* | 701.2M* | 1.0B* | 1.3B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | -.830 | -.790 | -.670 | .000 | .495 | .752 |
| Q1 | -.021 | -.200 | -.250 | -.050 | .050 | — |
| Q2 | -.060 | -.150 | -.130 | .070 | .170 | — |
| Q3 | -.220 | -.190 | -.140 | .020 | .060 | — |
| Q4 | -.314* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| -.254* |
| -.163* |
| -.056* |
| .052 |
| — |